Open AccessRadiotherapy with temozolomide provides better survival in the newly diagnosed glioblastoma multiforme: A meta-analysis
Author(s) -
Chonghao Wang,
Na Zhu,
Linshu Wang,
Zhengce An
Publication year - 2015
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.168184
Subject(s) - temozolomide , medicine , meta analysis , radiation therapy , cochrane library , oncology , glioblastoma , confidence interval , medline , relative risk , cancer research , political science , law
The optimal treatment for patients with newly diagnosed glioblastoma multiforme (GBM) remains controversial. The purpose of this meta-analysis was to systematically evaluate radiotherapy/temozolomide (TMZ) versus radiotherapy for treating newly diagnosed GBM.